12:00 AM
Oct 20, 2016
 |  BC Innovations  |  Distillery Therapeutics

Endocrine / Metabolic


In vitro and mouse studies suggest a UCN2-based gene therapy could help treat Type II diabetes. In a mouse model of Type II diabetes, a single IV...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >